Skip to main content
. 2022 Feb 11;6(4):1126–1136. doi: 10.1182/bloodadvances.2021005862

Table 1.

Patient characteristics

Characteristic Total n = 75 691 n, (%)
Diagnosis
 Lymphoma 47 043 (62.2)
 Myeloma 13 057 (17.3)
 Leukemia 8 689 (11.5)
 Myelodysplastic syndromes 6 902 (9.1)
Sex
 Male 36 664 (48.4)
 Female 39 027 (51.6)
Age (ys)
 67-69 8 884 (11.7)
 70-74 17 325 (22.9)
 75-79 18 553 (24.5)
 ≥80 30 929 (40.9)
Race
 White 67 558 (89.3)
 Non-White 8 133 (10.7)
Ethnicity
 Non-Hispanic 72 089 (95.2)
 Hispanic 3 602 (4.8)
Marital status
 Married 38 869 (51.4)
 Not married 36 822 (48.6)
Residency
 Urban 74 079 (97.9)
 Rural 1 612 (2.1)
Education (census tract quintile) *
 1 (lowest) 16 361 (21.6)
 2 14 855 (19.6)
 3 14 777 (19.5)
 4 14 833 (19.6)
 5 (highest) 14 865 (19.6)
Median income (census tract quintile)
 1 (lowest) 15 587 (20.6)
 2 14 688 (19.4)
 3 14 879 (19.7)
 4 14 989 (19.8)
 5 (highest) 15 548 (20.5)
Surveillance, Epidemiology, and End Results registry region
 Midwest 9 996 (13.2)
 Northeast 18 898 (25.0)
 South 18 183 (24.0)
 West 28 614 (37.8)
Charlson Comorbidity Index
 0 37 979 (50.2)
 1 18 166 (24.0)
 2+ 19 546 (25.8)
Year of diagnosis
 2000-2003 17 864 (23.6)
 2004-2007 19 835 (26.2)
 2008-2011 19 386 (25.6)
 2012-2015 18 606 (24.6)
*

Quintiles based on percentage of individuals 25 yrs and older with some college education in a census tract.

Quintiles based on the median household or per capita income within each census tract.